BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14535586)

  • 1. Evaluation of sample handling in relation to levels of tissue inhibitor of metalloproteinases-1 measured in blood by immunoassay.
    Holten-Andersen MN; Schrohl AS; Brünner N; Nielsen HJ; Høgdall CK; Høgdall EV
    Int J Biol Markers; 2003; 18(3):170-6. PubMed ID: 14535586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dependence of TIMP-1 plasma levels on preanalytical specimen handling.
    Dresse M; Nagel D; Ganser EM; Davis G; Dowell B; Doss R; Stieber P
    Tumour Biol; 2008; 29(1):35-40. PubMed ID: 18497547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of cryopreservation on serum concentration of matrix metalloproteinases (MMP)-7, TIMP-1, vascular growth factors (VEGF) and VEGF-R2 in Biobank samples.
    Kisand K; Kerna I; Kumm J; Jonsson H; Tamm A
    Clin Chem Lab Med; 2011 Feb; 49(2):229-35. PubMed ID: 21118050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble urokinase plasminogen activator receptor measurements: influence of sample handling.
    Riisbro R; Christensen IJ; Høgdall C; Brünner N; Høgdall E
    Int J Biol Markers; 2001; 16(4):233-9. PubMed ID: 11820717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.
    Sørensen NM; Schrohl AS; Jensen V; Christensen IJ; Nielsen HJ; Brünner N
    Scand J Gastroenterol; 2008; 43(2):186-91. PubMed ID: 18224564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood.
    Lein M; Nowak L; Jung K; Koenig F; Lichtinghagen R; Schnorr D; Loening SA
    Clin Biochem; 1997 Aug; 30(6):491-6. PubMed ID: 9316744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the effects of repeated freeze thawing and extended bench top processing of plasma samples using untargeted metabolomics.
    Goodman K; Mitchell M; Evans AM; Miller LAD; Ford L; Wittmann B; Kennedy AD; Toal D
    Metabolomics; 2021 Mar; 17(3):31. PubMed ID: 33704583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tissue inhibitor of metalloproteinases-1 as a biological marker? Pre-analytical considerations.
    Lomholt AF; Frederiksen CB; Christensen IJ; Brünner N; Nielsen HJ
    Clin Chim Acta; 2007 May; 380(1-2):128-32. PubMed ID: 17328880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.
    Frederiksen CB; Lomholt AF; Lottenburger T; Davis GJ; Dowell BL; Blankenstein MA; Christensen IJ; Brunner N; Nielsen HJ
    Int J Biol Markers; 2008; 23(1):42-7. PubMed ID: 18409150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.
    Rossignol P; Cambillau M; Bissery A; Mouradian D; Benetos A; Michel JB; Plouin PF; Chatellier G; Jacob MP
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):464-9. PubMed ID: 18307742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preanalytical study of fetuin-A: effect of sample type, processing speed and freeze-thaw cycles.
    McArthur L; Johnston L; Sattar N; Logue J; Welsh P
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):165-8. PubMed ID: 24696154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong impact on plasma protein profiles by precentrifugation delay but not by repeated freeze-thaw cycles, as analyzed using multiplex proximity extension assays.
    Shen Q; Björkesten J; Galli J; Ekman D; Broberg J; Nordberg N; Tillander A; Kamali-Moghaddam M; Tybring G; Landegren U
    Clin Chem Lab Med; 2018 Mar; 56(4):582-594. PubMed ID: 29040064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the anticoagulant, storage time and temperature of blood samples on the concentrations of 27 multiplex assayed cytokines - Consequences for defining reference values in healthy humans.
    Hennø LT; Storjord E; Christiansen D; Bergseth G; Ludviksen JK; Fure H; Barene S; Nielsen EW; Mollnes TE; Brekke OL
    Cytokine; 2017 Sep; 97():86-95. PubMed ID: 28595117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.
    Holten-Andersen MN; Christensen IJ; Nielsen HJ; Lilja H; Murphy G; Jensen V; Brünner N; Piironen T
    Clin Chem; 2002 Aug; 48(8):1305-13. PubMed ID: 12142388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of serum and plasma osmolality in healthy young humans--influence of time and storage conditions.
    Seifarth CC; Miertschischk J; Hahn EG; Hensen J
    Clin Chem Lab Med; 2004; 42(8):927-32. PubMed ID: 15387444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples.
    Piironen T; Pettersson K; Suonpää M; Stenman UH; Oesterling JE; Lövgren T; Lilja H
    Urology; 1996 Dec; 48(6A Suppl):81-7. PubMed ID: 8973706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pre-analytical variables on VEGF gene expression and circulating protein concentrations.
    Azimi-Nezhad M; Lambert D; Ottone C; Perrin C; Chapel C; Gaillard G; Pfister M; Masson C; Tabone E; Betsou F; Meyronet D; Ungeheuer MN; Siest SV
    Biopreserv Biobank; 2012 Oct; 10(5):454-61. PubMed ID: 24845047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients.
    Raiko I; Sander I; Weber DG; Raulf-Heimsoth M; Gillissen A; Kollmeier J; Scherpereel A; Brüning T; Johnen G
    BMC Cancer; 2010 May; 10():242. PubMed ID: 20509881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of freezing and thawing of serum on the immunoassay of lipoprotein(a).
    Sgoutas DS; Tuten T
    Clin Chem; 1992 Sep; 38(9):1873-7. PubMed ID: 1388112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer.
    Holten-Andersen MN; Murphy G; Nielsen HJ; Pedersen AN; Christensen IJ; Høyer-Hansen G; Brünner N; Stephens RW
    Br J Cancer; 1999 May; 80(3-4):495-503. PubMed ID: 10408859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.